Fig. 4From: Clinical and prognostic value of tumor volumetric parameters in melanoma patients undergoing 18F-FDG-PET/CT: a comparison with serologic markers of tumor burden and inflammation(a) Estimated overall survival in patients with elevated serum LDH (36.5 ± 4.9 months) compared to patients with normal serum LDH (49.2 ± 2.4 months, p = 0.01) and (b) in patients with elevated serum S-100 protein (37.9 ± 4.4 months) compared to patients with normal serum S-100 protein (49.0 ± 2.5 months, p = 0.01)Back to article page